Valuation

Eli Lilly DCF Valuation

DCF valuation incorporating pharmaceutical pipeline analysis. Revenue projections are probability-weighted by drug approval stage. Includes comparable company analysis.

Full case study coming soon.

The interactive write-up for this project is in progress. Check back shortly.

Key Highlights

▸Pipeline-adjusted revenue projections

▸Probability-weighted drug approval scenarios

▸Comparable company analysis

Technologies

DCFPharmaValuationScenario Analysis